Pages that link to "Q36203732"

The following pages link to HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis (Q36203732):

Displaying 48 items.

• Interaction of paroxetine with mitochondrial proteins mediates neuroprotection (Q27339182) (← links)
• The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons (Q30738175) (← links)
• Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system (Q33610280) (← links)
• HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation (Q33647438) (← links)
• Putative mechanisms of cognitive dysfunction in chemotherapy-naïve diffuse large B-cell lymphoma: a case report and review of the literature. (Q33676032) (← links)
• High-performance capillary electrophoresis for determining HIV-1 Tat protein in neurons (Q33797753) (← links)
• Glutamate metabolism and HIV-associated neurocognitive disorders (Q33903612) (← links)
• Reduction of pyramidal and immature hippocampal neurons in pediatric simian immunodeficiency virus infection (Q34028721) (← links)
• Gene expression analysis in the thalamus and cerebrum of horses experimentally infected with West Nile virus (Q34047030) (← links)
• Neuroprotective activity of pDING in response to HIV-1 Tat. (Q34377554) (← links)
• The impact of HIV-1 on neurogenesis: implications for HAND (Q34472345) (← links)
• Cognitive impairment in patients with AIDS - prevalence and severity (Q35057500) (← links)
• Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. (Q35266342) (← links)
• Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection? (Q35984276) (← links)
• Envelope gene evolution and HIV-1 neuropathogenesis (Q36847475) (← links)
• Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders (Q36868552) (← links)
• Mitogen-activated protein kinase p38 in HIV infection and associated brain injury (Q36950000) (← links)
• Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury (Q36950047) (← links)
• Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders (Q37254517) (← links)
• Targeting anti-HIV drugs to the CNS. (Q37368323) (← links)
• NFκB signaling regulates embryonic and adult neurogenesis (Q37373888) (← links)
• HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches (Q37418815) (← links)
• Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND). (Q37432530) (← links)
• Virus-induced transcriptional changes in the brain include the differential expression of genes associated with interferon, apoptosis, interleukin 17 receptor A, and glutamate signaling as well as flavivirus-specific upregulation of tRNA synthetases (Q37634452) (← links)
• Productive infection of human neural progenitor cells by R5 tropic HIV-1: opiate co-exposure heightens infectivity and functional vulnerability (Q37689277) (← links)
• Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND. (Q37721505) (← links)
• Subventricular zone under the neuroinflammatory stress and Parkinson's disease (Q37970601) (← links)
• Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways (Q38122650) (← links)
• Innate immune responses to HIV infection in the central nervous system (Q38160779) (← links)
• Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy (Q38210096) (← links)
• Progressive MS: from pathophysiology to drug discovery (Q38585418) (← links)
• Phosphorylation of collapsin response mediator protein-2 disrupts neuronal maturation in a model of adult neurogenesis: Implications for neurodegenerative disorders (Q38868081) (← links)
• Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics (Q38882614) (← links)
• HIV-1 Vpr deregulates calcium secretion in neural cells (Q39867301) (← links)
• Involvement of the p53 and p73 transcription factors in neuroAIDS. (Q39948335) (← links)
• HIV-1 Glycoprotein 120 Enhancement of N-Methyl-D-Aspartate NMDA Receptor-Mediated Excitatory Postsynaptic Currents: Implications for HIV-1-Associated Neural Injury. (Q40412103) (← links)
• HIV-1 gp120-Mediated Mitochondrial Dysfunction and HIV-Associated Neurological Disorders (Q40717315) (← links)
• Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting (Q42262319) (← links)
• Distemper virus encephalitis exerts detrimental effects on hippocampal neurogenesis (Q44271737) (← links)
• Impact of Theiler's virus infection on hippocampal neuronal progenitor cells: differential effects in two mouse strains (Q45360064) (← links)
• Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. (Q46229748) (← links)
• Neural stem cells in the ischemic and injured brain: endogenous and transplanted (Q48764024) (← links)
• Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders (Q49824521) (← links)
• Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux? (Q52627559) (← links)
• BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism. (Q52720530) (← links)
• Astrocytes contacting HIV-1-infected macrophages increase the release of CCL2 in response to the HIV-1-dependent enhancement of membrane-associated TNFα in macrophages. (Q55463909) (← links)
• Adult neurogenic deficits in HIV-1 Tg26 transgenic mice (Q57471600) (← links)
• Role of the inflammasomes in HIV-associated neuroinflammation and neurocognitive disorders (Q92684391) (← links)